FDA Import Refusal AEK-7236284-9/12/1 — Boehringer Ingelheim

Boehringer Ingelheim — FEI 3012555240

The FDA refused shipment AEK-7236284-9/12/1 from Boehringer Ingelheim (India) on Jul 7, 2025. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.